AYTU: AYTU BIOPHARMA, INC insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | LYTTON LAURENCE W | 4.99% | SEC |
Institutional ownership (Q2 2026)
38 institutions reported holding $10.56M of AYTU BIOPHARMA, INC on Form 13F (37 the quarter before). 3 opened a new position and 2 sold out. Shares held by institutions: +26%.
| Largest holders | Shares | Value |
|---|---|---|
| Nantahala Capital Management, LLC | 2,173,624 | $4.67M |
| Stonepine Capital Management, LLC | 912,921 | $1.96M |
| AWM Investment Company, Inc. | 619,574 | $1.33M |
| VANGUARD CAPITAL MANAGEMENT LLC | 261,146 | $561K |
| CROWN ADVISORS MANAGEMENT, INC. | 200,000 | $430K |
| DIADEMA PARTNERS LP | 148,546 | $319K |
| TWO SIGMA INVESTMENTS, LP | 105,326 | $226K |
| RENAISSANCE TECHNOLOGIES LLC | 104,823 | $225K |
| GEODE CAPITAL MANAGEMENT, LLC | 93,647 | $201K |
| CITADEL ADVISORS LLC | 49,414 | $106K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.